Phosphoinositide-specific phospholipase C in health and disease

Journal of Lipid Research

Volumn 56, Issue 10, 2015, Pages 1853-1860

  Cocco, Lucio ^a   Follo, Matilde Y ^a   Manzoli, Lucia ^a   Suh, Pann Ghill ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ulsan National Institute of Science and Technology   (South Korea)

Author keywords

Enzyme regulation; Function; Signal transduction

Indexed keywords

CALCIUM ION; ISOENZYME; PHOSPHATIDYLINOSITIDE SPECIFIC PHOSPHOLIPASE C; PHOSPHATIDYLINOSITIDE SPECIFIC PHOSPHOLIPASE C BETA; PHOSPHATIDYLINOSITIDE SPECIFIC PHOSPHOLIPASE C EPSILON; PHOSPHATIDYLINOSITIDE SPECIFIC PHOSPHOLIPASE C ETA; PHOSPHATIDYLINOSITIDE SPECIFIC PHOSPHOLIPASE C GAMMA; PHOSPHATIDYLINOSITIDE SPECIFIC PHOSPHOLIPASE C ZETA; PHOSPHOLIPASE C; UNCLASSIFIED DRUG; DIACYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE;

ACUTE MYELOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; COLORECTAL CANCER; EMBRYO MORTALITY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME REGULATION; GENETIC VARIABILITY; HUMAN; INTRACELLULAR SIGNALING; MYELODYSPLASTIC SYNDROME; NONHUMAN; PI PLCBETA GENE; PI PLCDELTA GENE; PI PLCEPSILON GENE; PI PLCETA GENE; PI PLCGAMMA GENE; PI PLCZETA GENE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REVIEW; RNA SPLICING; VASCULAR DISEASE; ALTERNATIVE RNA SPLICING; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; DIGLYCERIDES; ENZYME ACTIVATION; HUMANS; PHOSPHATIDYLINOSITOLS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; SIGNAL TRANSDUCTION;

EID: 84937237382     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R057984     Document Type: Review

References (93)

1. Nakamura, Y., K. Awai, T. Masuda, Y. Yoshioka, K. Takamiya, and H. Ohta. 2005. A novel phosphatidylcholine-hydrolyzing phospho-lipase C induced by phosphate starvation in Arabidopsis. J. Biol. Chem. 280: 7469-7476.
2. Peters, C., M. Li, R. Narasimhan, M. Roth, R. Welti, and X. Wang. 2010. Nonspecific phospholipase C NPC4 promotes responses to abscisic acid and tolerance to hyperosmotic stress in Arabidopsis. Plant Cell. 22: 2642-2659.
3. Abalsamo, L., F. Spadaro, G. Bozzuto, L. Paris, S. Cecchetti, L. Lugini, E. Iorio, A. Molinari, C. Ramoni, and F. Podo. 2012. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells. Breast Cancer Res. 14: R50.
4. Poli, A., S. Mongiorgi, L. Cocco, and M. Y. Follo. 2014. Protein kinase C involvement in cell cycle modulation. Biochem. Soc. Trans. 42: 1471-1476.
5. Follo, M. Y., L. Manzoli, A. Poli, J. A. McCubrey, and L. Cocco. 2015. PLC and PI3K/Akt/mTOR signalling in disease and cancer. Adv. Biol. Regul. 57: 10-16.
6. Hokin, L. E., and M. R. Hokin. 1953. The incorporation of 32P into the nucleotides of ribonucleic acid in pigeon pancreas slices. Biochim. Biophys. Acta. 11: 591-592.
7. Yang, Y. R., M. Y. Follo, L. Cocco, and P. G. Suh. 2013. The physiological roles of primary phospholipase C. Adv. Biol. Regul. 53: 232-241.
8. Rhee, S. G. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70: 281-312.
9. Essen, L. O., O. Perisic, R. Cheung, M. Katan, and R. L. Williams. 1996. Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta. Nature. 380: 595-602.
10. Paterson, H. F., J. W. Savopoulos, O. Perisic, R. Cheung, M. V. Ellis, R. L. Williams, and M. Katan. 1995. Phospholipase C delta 1 requires a pleckstrin homology domain for interaction with the plasma membrane. Biochem. J. 312: 661-666.
11. Wang, T., L. Dowal, M. R. El-Maghrabi, M. Rebecchi, and S. Scarlata. 2000. The pleckstrin homology domain of phospholipase C-beta(2) links the binding of gbetagamma to activation of the catalytic core. J. Biol. Chem. 275: 7466-7469.
12. Falasca, M., S. K. Logan, V. P. Lehto, G. Baccante, M. A. Lemmon, and J. Schlessinger. 1998. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17: 414-422.
13. Wen, W., J. Yan, and M. Zhang. 2006. Structural characterization of the split pleckstrin homology domain in phospholipase C-gamma1 and its interaction with TRPC3. J. Biol. Chem. 281: 12060-12068.
14. Nakashima, S., Y. Banno, T. Watanabe, Y Nakamura, T. Mizutani, H. Sakai, Y Zhao, Y Sugimoto, and Y Nozawa. 1995. Deletion and site-directed mutagenesis of EF-hand domain of phospholipase C-delta 1: effects on its activity. Biochem. Biophys. Res. Commun. 211: 365-369.
15. Otterhag, L., M. Sommarin, and C. Pical. 2001. N-terminal EF-hand-like domain is required for phosphoinositide-specific phospholipase C activity in Arabidopsis thaliana. FEBS Lett. 497: 165-170.
16. Rhee, S. G. 2013. Reflections on the days of phospholipase C. Adv. Biol. Regul. 53: 223-231.
17. Rebecchi, M. J., and S. N. Pentyala. 2000. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80: 1291-1335.
18. Drin, G., and S. Scarlata. 2007. Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding-how many ways can you activate an enzyme? Cell. Signal. 19: 1383-1392.
19. Ross, E. M., D. Mateu, A. V. Gomes, C. Arana, T. Tran, and I. Litosch. 2006. Structural determinants for phosphatidic acid regulation of phospholipase C-beta1. J. Biol. Chem. 281: 33087-33094.
20. Cockcroft, S., and K. Garner. 2013. Potential role for phosphati-dylinositol transfer protein (PITP) family in lipid transfer during phospholipase C signalling. Adv. Biol. Regul. 53: 280-291.
21. Sânchez-Fernândez, G., S. Cabezudo, C. García-Hoz, C. Benincâ, A M. Aragay, F. Mayor, Jr., and C. Ribas. 2014. Galphaq signalling: the new and the old. Cell. Signal. 26: 833-848.
22. Faenza, I., A. M. Billi, M. Y Follo, R. Fiume, A. M. Martelli, L. Cocco, and L. Manzoli. 2005. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation. Anticancer Res. 25: 2039-2041.
23. Martelli, A. M., R. Fiume, I. Faenza, G. Tabellini, C. Evangelista, R. Bortul, M. Y Follo, F. Fala, and L. Cocco. 2005. Nuclear phos-phoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. Histol. Histopathol. 20: 1251-1260.
24. Blind, R. D. 2014. Disentangling biological signaling networks by dynamic coupling of signaling lipids to modifying enzymes. Adv. Biol. Regul. 54: 25-38.
25. Park, D., D. Y Jhon, C. W. Lee, S. H. Ryu, and S. G. Rhee. 1993. Removal of the carboxyl-terminal region of phospholipase C-beta 1 by calpain abolishes activation by G alpha q. J. Biol. Chem. 268: 3710-3714.
26. Smrcka, A. V., and P. C. Sternweis. 1993. Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. J. Biol. Chem. 268: 9667-9674.
27. Camps, M., A. Carozzi, P. Schnabel, A. Scheer, P. J. Parker, and P. Gierschik. 1992. Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature. 360: 684-686.
28. Lee, C. W., K. H. Lee, S. B. Lee, D. Park, and S. G. Rhee. 1994. Regulation of phospholipase C-beta 4 by ribonucleotides and the alpha subunit of Gq. J. Biol. Chem. 269: 25335-25338.
29. Kamat, A., and G. Carpenter. 1997. Phospholipase C-gamma1: reg-ulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev. 8: 109-117.
30. Marrero, M. B., W. G. Paxton, B. Schieffer, B. N. Ling, and K. E. Bernstein. 1996. Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell. Signal. 8: 21-26.
31. Venema, V. J., H. Ju, J. Sun, D. C. Eaton, M. B. Marrero, and R. C. Venema. 1998. Bradykinin stimulates the tyrosine phosphorylation and bradykinin B2 receptor association of phospholipase C gamma 1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 246: 70-75.
32. Sozzani, P., L. Hasan, M. H. Seguelas, D. Caput, P. Ferrara, B. Pipy, and C. Cambon. 1998. IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Biochem. Biophys. Res. Commun. 244: 665-670.
33. Espagnolle, N., D. Depoil, R. Zaru, C. Demeur, E. Champagne, M. Guiraud, and S. Valitutti. 2007. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the im-munological synapse. Int. Immunol. 19: 239-248.
34. Kurosaki, T., A. Maeda, M. Ishiai, A. Hashimoto, K. Inabe, and M. Takata. 2000. Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol. Rev. 176: 19-29.
35. Watson, S. P., J. M. Auger, O. J. McCarty, and A. C. Pearce. 2005. GPVI and integrin alphaIIb beta3 signaling in platelets. J. Thromb. Haemost. 3: 1752-1762.
36. Wen, R., S. T. Jou, Y. Chen, A. Hoffmeyer, and D. Wang. 2002. Phospholipase C gamma 2 is essential for specific functions of Fc epsilon R and Fc gamma R. J. Immunol. 169: 6743-6752.
37. Smrcka, A. V., J. H. Brown, and G. G. Holz. 2012. Role of phos-pholipase Cepsilon in physiological phosphoinositide signaling networks. Cell. Signal. 24: 1333-1343.
38. Jin, T. G., T. Satoh, Y. Liao, C. Song, X. Gao, K. Kariya, C. D. Hu, and T. Kataoka. 2001. Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling. J. Biol. Chem. 276: 30301-30307.
39. Kim, Y. H., T. J. Park, Y. H. Lee, K. J. Baek, P. G. Suh, S. H. Ryu, and K. T. Kim. 1999. Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J. Biol. Chem. 274: 26127-26134.
40. Allen, V., P. Swigart, R. Cheung, S. Cockcroft, and M. Katan. 1997. Regulation of inositol lipid-specific phospholipase cdelta by changes in Ca2+ ion concentrations. Biochem. J. 327: 545-552.
41. Cockcroft, S. 2006. The latest phospholipase C, PLCeta, is impli-cated in neuronal function. Trends Biochem. Sci. 31: 4-7.
42. Cho, J. H., M. S. Yoon, J. B. Koo, Y. S. Kim, K. S. Lee, J. H. Lee, and J. S. Han. 2011. The progesterone receptor as a transcription factor regulates phospholipase D1 expression through independent activation of protein kinase A and Ras during 8-Br-cAMP-induced de-cidualization in human endometrial stromal cells. Biochem. J. 436: 181-191.
43. Okubo, Y., S. Kakizawa, K. Hirose, and M. Iino. 2001. Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca(2+) influx in Purkinje cells. Neuron. 32: 113-122.
44. Thore, S., O. Dyachok, E. Gylfe, and A. Tengholm. 2005. Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca2+ in insulin-secreting beta-cells. J. Cell Sci. 118: 4463-4471.
45. Thore, S., O. Dyachok, and A. Tengholm. 2004. Oscillations of phospholipase C activity triggered by depolarization and Ca2+ in-flux in insulin-secreting cells. J. Biol. Chem. 279: 19396-19400.
46. Young, K. W., M. S. Nash, R. A. Challiss, and S. R. Nahorski. 2003. Role of Ca2+ feedback on single cell inositol 1, 4, 5-trisphosphate oscillations mediated by G-protein-coupled receptors. J. Biol. Chem. 278: 20753-20760.
47. Peruzzi, D., M. Aluigi, L. Manzoli, A. M. Billi, F. P. Di Giorgio, M. Morleo, A. M. Martelli, and L. Cocco. 2002. Molecular characterization of the human PLC beta1 gene. Biochim. Biophys. Acta. 1584: 46-54.
48. Bahk, Y. Y., H. Song, S. H. Baek, B. Y. Park, H. Kim, S. H. Ryu, and P. G. Suh. 1998. Localization of two forms of phospholipase C-beta1, a and b, in C6Bu-1 cells. Biochim. Biophys. Acta. 1389: 76-80.
49. Mao, G. F., S. P. Kunapuli, and A. Koneti Rao. 2000. Evidence for two alternatively spliced forms of phospholipase C-beta2 in haematopoietic cells. Br. J. Haematol. 110: 402-408.
50. Kim, M. J., D. S. Min, S. H. Ryu, and P. G. Suh. 1998. A cytosolic, galphaq-and betagamma-insensitive splice variant of phospholi-pase C-beta4. J. Biol. Chem. 273: 3618-3624.
51. Lee, S. B., and S. G. Rhee. 1996. Molecular cloning, splice variants, expression, and purification of phospholipase C-delta 4. J. Biol. Chem. 271: 25-31.
52. Sorli, S. C., T. D. Bunney, P. H. Sugden, H. F. Paterson, and M. Katan. 2005. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene. 24: 90-100.
53. Sun, L., G. Mao, S. P. Kunapuli, D. N. Dhanasekaran, and A. K. Rao. 2007. Alternative splice variants of phospholipase C-beta2 are expressed in platelets: effect on Galphaq-dependent activation and localization. Platelets. 18: 217-223.
54. Min, D. S., D. M. Kim, Y. H. Lee, J. Seo, P. G. Suh, and S. H. Ryu. 1993. Purification of a novel phospholipase C isozyme from bovine cerebellum. J. Biol. Chem. 268: 12207-12212.
55. Adamski, F. M., K. M. Timms, and B. H. Shieh. 1999. A unique iso-form of phospholipase Cbeta4 highly expressed in the cerebellum and eye. Biochim. Biophys. Acta. 1444: 55-60.
56. Upshaw, J. L., R. A. Schoon, C. J. Dick, D. D. Billadeau, and P. J. Leibson. 2005. The isoforms of phospholipase C-gamma are differentially used by distinct human NK activating receptors. J. Immunol. 175: 213-218.
57. Ishikawa, S., T. Takahashi, M. Ogawa, and Y. Nakamura. 1997. Genomic structure of the human PLCD1 (phospholipase C delta 1) locus on 3p22 → p21.3. Cytogenet. Cell Genet. 78: 58-60.
58. Fukami, K., T. Inoue, M. Kurokawa, R. A. Fissore, K. Nakao, K. Nagano, Y. Nakamura, K. Takenaka, N. Yoshida, K. Mikoshiba, et al. 2003. Phospholipase Cdelta4: from genome structure to physiological function. Adv. Enzyme Regul. 43: 87-106.
59. Kouchi, Z., K. Fukami, T. Shikano, S. Oda, Y. Nakamura, T. Takenawa, and S. Miyazaki. 2004. Recombinant phospholipase Czeta has high Ca2+ sensitivity and induces Ca2+ oscillations in mouse eggs. J. Biol. Chem. 279: 10408-10412.
60. Hwang, J. I., Y. S. Oh, K. J. Shin, H. Kim, S. H. Ryu, and P. G. Suh. 2005. Molecular cloning and characterization of a novel phospho-lipase C, PLC-eta. Biochem. J. 389: 181-186.
61. Zhou, Y., M. R. Wing, J. Sondek, and T. K. Harden. 2005. Molecular cloning and characterization of PLC-eta2. Biochem. J. 391: 667-676.
62. Ramazzotti, G., I. Faenza, M. Y. Follo, R. Fiume, M. Piazzi, R. Giardino, M. Fini, and L. Cocco. 2011. Nuclear phospholipase C in biological control and cancer. Crit. Rev. Eukaryot. Gene Expr. 21: 291-301.
63. Follo, M. Y., I. Faenza, R. Fiume, G. Ramazzotti, J. A. McCubrey, A. M. Martelli, F. A. Manzoli, and L. Cocco. 2012. Revisiting nuclear phospholipase C signalling in MDS. Adv. Biol. Regul. 52: 2-6.
64. Follo, M. Y., S. Marmiroli, I. Faenza, R. Fiume, G. Ramazzotti, A. M. Martelli, P. Gobbi, J. A. McCubrey, C. Finelli, F. A. Manzoli, et al. 2013. Nuclear phospholipase C beta1 signaling, epigenetics and treatments in MDS. Adv. Biol. Regul. 53: 2-7.
65. Follo, M. Y., I. Faenza, M. Piazzi, W. L. Blalock, L. Manzoli, J. A. McCubrey, and L. Cocco. 2014. Nuclear PI-PLCbeta1: an appraisal on targets and pathology. Adv. Biol. Regul. 54: 2-11.
66. Koh, H. Y. 2013. Phospholipase C-beta1 and schizophrenia-related behaviors. Adv. Biol. Regul. 53: 242-248.
67. Fukaya, M., M. Uchigashima, S. Nomura, Y. Hasegawa, H. Kikuchi, and M. Watanabe. 2008. Predominant expression of phospholipase Cbeta1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements. Eur. J. Neurosci. 28: 1744-1759.
68. Watanabe, M., M. Nakamura, K. Sato, M. Kano, M. I. Simon, and Y. Inoue. 1998. Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cbeta in mouse brain. Eur. J. Neurosci. 10: 2016-2025.
69. Lin, X. H., N. Kitamura, T. Hashimoto, O. Shirakawa, and K. Maeda. 1999. Opposite changes in phosphoinositide-specific phospholi-pase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia. Biol. Psychiatry. 46: 1665-1671.
70. Shirakawa, O., N. Kitamura, X. H. Lin, T. Hashimoto, and K. Maeda. 2001. Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 25: 867-877.
71. Lo Vasco, V. R., L. Longo, and P. Polonia. 2013. Phosphoinositide-specific phospholipase C beta1 gene deletion in bipolar disorder affected patient. J. Cell Commun. Signal. 7: 25-29.
72. Kawakami, T., and W. Xiao. 2013. Phospholipase C-beta in immune cells. Adv. Biol. Regul. 53: 249-257.
73. Li, Z., H. Jiang, W. Xie, Z. Zhang, A. V. Smrcka, and D. Wu. 2000. Roles of PLC-beta2 and-beta3 and PI3Kgamma in chemoattrac-tant-mediated signal transduction. Science. 287: 1046-1049.
74. Wang, Z., B. Liu, P. Wang, X. Dong, C. Fernandez-Hernando, Z. Li, T. Hla, K. Claffey, J. D. Smith, and D. Wu. 2008. Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. J. Clin. Invest. 118: 195-204.
75. Xiao, W., H. Hong, Y. Kawakami, Y. Kato, D. Wu, H. Yasudo, A. Kimura, H. Kubagawa, L. F. Bertoli, R. S. Davis, et al. 2009. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephos-phorylation of Stat5. Cancer Cell. 16: 161-171.
76. Follo, M. Y., S. Mongiorgi, C. Finelli, M. Piazzi, I. Faenza, G. Ramazzotti, P. Santi, J. A. McCubrey, A. M. Martelli, and L. Cocco. 2012. Nuclear PI-PLCbeta1 and myelodysplastic syndromes: genetics and epigenetics. Curr. Pharm. Des. 18: 1751-1754.
77. Cocco, L., I. Faenza, M. Y. Follo, G. Ramazzotti, G. C. Gaboardi, A. M. Billi, A. M. Martelli, and L. Manzoli. 2008. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes. Adv. Enzyme Regul. 48: 2-9.
78. Mongiorgi, S., M. Y. Follo, C. Clissa, R. Giardino, M. Fini, L. Manzoli, G. Ramazzotti, R. Fiume, C. Finelli, and L. Cocco. 2012. Nuclear PI-PLC beta1 and myelodysplastic syndromes: from bench to clinics. Curr. Top. Microbiol. Immunol. 362: 235-245.
79. Ramazzotti, G., I. Faenza, R. Fiume, A. Matteucci, M. Piazzi, M. Y. Follo, and L. Cocco. 2011. The physiology and pathology of inositide signaling in the nucleus. J. Cell. Physiol. 226: 14-20.
80. Follo, M. Y., C. Finelli, C. Clissa, S. Mongiorgi, C. Bosi, G. Martinelli, M. Baccarani, L. Manzoli, A. M. Martelli, and L. Cocco. 2009. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute my-eloid leukemia. J. Clin. Oncol. 27: 782-790.
81. Follo, M. Y., S. Mongiorgi, C. Finelli, C. Clissa, G. Ramazzotti, R. Fiume, I. Faenza, L. Manzoli, A. M. Martelli, and L. Cocco. 2010. Nuclear inositide signaling in myelodysplastic syndromes. J. Cell. Biochem. 109: 1065-1071.
82. Manzoli, L., S. Mongiorgi, C. Clissa, C. Finelli, A. M. Billi, A. Poli, M. Quaranta, L. Cocco, and M. Y. Follo. 2014. Strategic role of nuclear inositide signalling in myelodysplastic syndromes therapy. Mini Rev. Med. Chem. 14: 873-883.
83. Follo, M. Y., C. Finelli, S. Mongiorgi, C. Clissa, C. Bosi, N. Testoni, F. Chiarini, G. Ramazzotti, M. Baccarani, A. M. Martelli, et al. 2009. Reduction of phosphoinositide-phospholipase C beta1 methyla-tion predicts the responsiveness to azacitidine in high-risk MDS. Proc. Natl. Acad. Sci. USA. 106: 16811-16816.
84. Follo, M. Y., C. Finelli, S. Mongiorgi, C. Clissa, F. Chiarini, G. Ramazzotti, S. Paolini, G. Martinelli, A. M. Martelli, and L. Cocco. 2011. Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes. Leukemia. 25: 271-280.
85. Follo, M. Y., D. Russo, C. Finelli, S. Mongiorgi, C. Clissa, C. Fili, C. Colombi, M. Gobbi, L. Manzoli, M. Piazzi, et al. 2012. Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment. Leukemia. 26: 943-950.
86. Philip, F., S. Sahu, G. Caso, and S. Scarlata. 2013. Role of phos-pholipase C-beta in RNA interference. Adv. Biol. Regul. 53: 319-330.
87. Lattanzio, R., M. Piantelli, and M. Falasca. 2013. Role of phospholi-pase C in cell invasion and metastasis. Adv. Biol. Regul. 53: 309-318.
88. Chan, J. J., and M. Katan. 2013. PLCvarepsilon and the RASSF fam-ily in tumour suppression and other functions. Adv. Biol. Regul. 53: 258-279.
89. Chan, J. J., D. Flatters, F. Rodrigues-Lima, J. Yan, K. Thalassinos, and M. Katan. 2013. Comparative analysis of interactions of RASSF1-10. Adv. Biol. Regul. 53: 190-201.
90. Wang, X., C. Zhou, G. Qiu, Y. Yang, D. Yan, T. Xing, J. Fan, H. Tang, and Z. Peng. 2012. Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med. Oncol. 29: 1051-1058.
91. Nomikos, M., J. Kashir, K. Swann, and F. A. Lai. 2013. Sperm PLCzeta: from structure to Ca2+ oscillations, egg activation and therapeutic potential. FEBS Lett. 587: 3609-3616.
92. Amdani, S. N., C. Jones, and K. Coward. 2013. Phospholipase C zeta (PLCzeta): oocyte activation and clinical links to male factor infertility. Adv. Biol. Regul. 53: 292-308.
93. Nakamura, Y., K. Kanemarum, and K. Fukami. 2013. Physiological functions of phospholipase Cdelta1 and phospholipase Cdelta3. Adv. Biol. Regul. 53: 356-362.